Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-09

Clinical Trial Update: First in Human Study in Subjects With Obesity, But Otherwise Healthy [Phase 1]

View source ↗

Summary

NeuroBo Pharmaceuticals announced a first-in-human Phase 1 study in adults with obesity (who are otherwise healthy), and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Obesity | Phase 1 | Status: RECRUITING